Following the success of the first 2 years of the LNP Formulation & Process Development Summit, we are hugely excited to announce the much-anticipated return of this world-leading summit in 2024.

This April, the 3rd LNP Formulation & Process Development Summit returns to Boston, bringing together over 400 experts in LNP Biology, Chemistry, Formulation, Analytical Development, Process Development, Manufacturing and more. This is your ultimate platform for sharing insights, learning new concepts and networking to propel more LNPs into the clinic in 2024.

Join the ever-growing community of LNP pioneers as they tackle the challenges associated with developing safe, compliant and efficacious LNPs, to treat a variety of disease indications at a variety of target organs. This starts with the in vitro discovery of LNPs through to the manufacturing processes, with end-to-end synergy fundamental.

Hear from industry powerhouses Pfizer, Moderna, Alnylam and more, as well as new companies to share their insights to this community including Capstan Therapeutics, AbbVie, Mana Bio, Serina Therapeutics, Karma Biotechnologies and more.

With an expanded content offering and a 4-track, 4-day summit format, we continue to be the most comprehensive, premium LNP content available to industry. Part of this year’s content growth, the addition of the ‘LNP IP & Commercial Partnerships Focus Day’ has evolved with the current industry trends to secure long standing partnership to demonstrate clinical results, as well as gaining a further handle on the current IP and legal landscape.

To know more visit: https://ter.li/s96la3